phosphatidylcholines has been researched along with nafazatrom in 1 studies
Studies (phosphatidylcholines) | Trials (phosphatidylcholines) | Recent Studies (post-2010) (phosphatidylcholines) | Studies (nafazatrom) | Trials (nafazatrom) | Recent Studies (post-2010) (nafazatrom) |
---|---|---|---|---|---|
32,204 | 443 | 5,593 | 92 | 5 | 0 |
Protein | Taxonomy | phosphatidylcholines (IC50) | nafazatrom (IC50) |
---|---|---|---|
Polyunsaturated fatty acid 5-lipoxygenase | Rattus norvegicus (Norway rat) | 6.1667 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Gergèl, D; Hromadová, M; Ondrias, K; Ondriasovà, E; Stasko, A | 1 |
1 other study(ies) available for phosphatidylcholines and nafazatrom
Article | Year |
---|---|
Nafazatrom inhibits peroxidation of phosphatidylcholine liposomes, heart homogenate and low density lipoproteins.
Topics: Animals; Antioxidants; Electron Spin Resonance Spectroscopy; Fibrinolytic Agents; Heart; Humans; Lipid Peroxidation; Lipoproteins, LDL; Liposomes; Myocardium; Phosphatidylcholines; Pyrazoles; Pyrazolones; Rats; Vitamin E | 1997 |